Catalyst Wire Dossier Catalyst Wire Dossier

Vonaprument

vonaprument · Annexon, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vonaprument, covering 2025-11-06 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA) [Phase 3]

See pricing